Position in PFE
as of Jun 30, 2026
· filed Jul 6, 2026
Position Value
$1,674,499
-$294,470 QoQ
Shares Held
69,539
-0.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.62%
of 13F equity value
Holder Rank
#1,029
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026RDA Financial Network holds $10,624,897 across 8 Drug Manufacturers - General names. PFE ranks #2 (15.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,517 | $5,417,825 | |
| 2 | PFE |
Pfizer Inc
This page
|
69,539 | $1,674,499 | |
| 3 | JNJ |
Johnson & Johnson
|
5,338 | $1,355,691 | |
| 4 | ABBV |
AbbVie Inc.
|
3,122 | $785,620 | |
| 5 | BIIB |
Biogen Inc.
|
3,000 | $648,180 | |
| 6 | AMGN |
Amgen Inc
|
836 | $302,732 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
1,857 | $234,613 | |
| 8 | AZN |
Astrazeneca PLC
|
1,085 | $205,737 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,674,499 | 69,539 | Shares | Sole | 2026-07-06 | |
| 2026-03-31 | $1,968,969 | 70,120 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $1,727,985 | 69,397 | Shares | Sole | 2026-01-06 | |
| 2025-09-30 | $1,791,524 | 70,311 | Shares | Sole | 2025-10-08 | |
| 2025-06-30 | $1,642,720 | 67,769 | Shares | Sole | 2025-07-07 | |
| 2025-03-31 | $1,737,943 | 68,585 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $1,724,290 | 64,994 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $314,577 | 10,870 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $350,561 | 12,529 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $359,029 | 12,938 | Shares | Sole | 2024-04-11 | |
| 2023-12-31 | $344,846 | 11,978 | Shares | Sole | 2024-01-12 | |
| 2023-09-30 | $357,871 | 10,789 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $366,873 | 10,002 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $403,675 | 9,894 | Shares | Sole | 2023-04-12 | |
| 2022-12-31 | $517,062 | 10,091 | Shares | Sole | 2023-01-10 | |
| 2022-09-30 | $436,243 | 9,969 | Shares | Sole | 2022-10-11 | |
| 2022-06-30 | $520,996 | 9,937 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $509,313 | 9,838 | Shares | Sole | 2022-04-12 | |
| 2021-12-31 | $788,967 | 13,361 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $592,247 | 13,770 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $533,711 | 13,629 | Shares | Sole | 2021-07-13 | |
| 2021-03-31 | $488,163 | 13,474 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $449,008 | 12,198 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $507,817 | 13,837 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $417,350 | 12,763 | Shares | Sole | 2020-07-14 | |
| 2020-03-31 | $412,177 | 12,628 | Shares | Sole | 2020-04-06 | |
| No filing history on record for this holder in this stock. | ||||||